Atomic AI

Biotechnology company based in South San Francisco, California, specializing in AI-driven RNA drug discovery with atomic precision. The company integrates machine learning with structural biology to advance research and development, aiming to create more effective RNA-based therapeutics. Atomic AI primarily targets pharmaceutical companies and researchers focused on innovative drug discovery and development.